Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 451)
Posted On: 12/08/2021 11:27:28 AM
Post# of 154078
Posted By: CTMedic
Re: dfwl28 #111900
Dfwl,

It is important to recall that the critical population was a subgroup of the larger CD12 trial, rather than a separate trial. The subgroup analysis (I’m not certain if it was pre-specified. If not, is appropriately characterized as ad hoc/data mining) hit the p value for mortality and blew away p value for length of admission. Criteria for new trial evaluate length of admission/clinical improvement, rather than mortality.

With 4 doses IV and criteria excluding those intubated for more than 72 hours, there should be no issues demonstrating efficacy in critical covid.

As a bonus, trial time by Albert Einstein, not Amarex.













(7)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site